By Professor Sallie Pearson

Conference Presentations

Daniels B; Pearson S, 2017, 'Patterns of care and outcomes for long-term survivors with HER2-positive metastatic breast cancer (HER2+MBC) starting trastuzumab: An Australian whole-of-population cohort study', presented at Clinical Oncology Society of Australia Annual Scientific Meeting, 13 November 2017 - 15 November 2017

Daniels B; Pearson S, 2017, 'Did a policy to ease the prescribing restrictions for lapatinib as second-line HER2-positive metastatic breast cancer increase initiation rates?', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, QC, Canada, 26 August 2017 - 28 August 2018

Schaffer AL; Buckley NA; Dobbins TA; Degenhardt L; Larance B; Pearson S-A, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437103900349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Daniels B; Pearson S, 2016, 'Real-word use and outcomes of trastuzumab for metastatic breast cancer in Australia: Analysis of the Herceptin Program, 2001 – 2014', presented at Clinical Oncology Society of Australia Annual Scientific Meeting, Gold Coast, QLD, 15 November 2016 - 17 November 2016

Daniels B; Pearson S, 2016, 'Tracking trastuzumab (H) therapy in early- through late-stage HER2-positive breast cancer (HER2+BC) in Australia: A national, retrospective cohort study', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 26 August 2016 - 29 August 2016

Schaffer AL; pearson S; buckley N, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study.', presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.4070

joshi V; adelstein BA; Schaffer AL; srasuebkul P; EoCC Investigators ; dobbins T; pearson S, 2016, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', presented at 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.3512

Daniels B; Pearson S, 2016, 'Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early- through late-stage HER2-positive breast cancer (HER2+BC)', presented at International Population Data Linkage Conference, Swansea, Wales, UK, 23 August 2016 - 26 August 2016, http://dx.doi.org/10.23889/ijpds.v1i1.142

Schaffer AL; Buckley NA; Dobbins T; Banks E; Pearson S-A, 2015, 'Time Series Analysis of the Impact of Adverse Media on Statin Dispensing and Discontinuation in Australia'

Vajdic CM; Schaffer A; Dobbins TA; Ward RL; Barrett J; Er CC; Pearson S-A, 2014, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study', presented at 2014 World Cancer Congress, Melbourne, 03 December 2014 - 06 December 2014, http://dx.doi.org/10.1111/ajco.12332

Vajdic CM; Schaffer A; Dobbins TA; Barrett J; Ward RL; Er CC; Pearson S-A, 2014, 'HEALTH SERVICE UTILISATION AND INVESTIGATIONS BEFORE DIAGNOSIS OF CANCER OF UNKNOWN PRIMARY (CUP): A POPULATION-BASED NESTED CASE-CONTROL STUDY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Daniels B; Ward R; Pearson S-A, 2013, 'DO PHARMACEUTICAL CLAIMS ACCURATELY REFLECT ONCOLOGY PRESCRIBING PRACTICE: EVIDENCE FROM AN AUSTRALIAN HER2+EARLY BREAST CANCER COHORT (HER2EBC)', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Srasuebkul P; Ward R, 2013, 'HER2 POSITIVE EARLY BREAST CANCER (HER2EBC): AN AUSTRALIAN PATTERN OF CARE STUDY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stavrou E; Buckley N; Olivier J; Pearson S-A, 2012, 'Futile Drug Use at the End of Life? Continuation of Statins after a Cancer Diagnosis', presented at 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Barcelona, Spain, 23 August 2012 - 26 August 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000308131701017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Srasuebkul P; Drew A; Chen K; Ward R; Pearson S-A, 2011, 'Cardiotoxic Cancer Therapies in Australia: Which Patients Are Assessed for Cardiac Function?', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600550&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S; Ringland CL; Ward RL, 2008, 'Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000258420100067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Bruno C; Havard A; Gillies M; Coghill D; Brett J; Guastella A; Pearson S-A; Zoega H, 2022, 'Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084400136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Camacho X; Schaffer A; Buckley NA; Pratt N; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilization of tapentadol in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 543 - 544, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084402283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Daniels B; Luckett T; Falster MO; Liauw W; Gisev N; Pearson S-A, 2022, 'Understanding opioid use prior to and immediately following cancer diagnosis using group-based trajectory models (GBTM)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 525 - 526, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084402246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer AL; Brett J; Buckley NA; Pearson SA, 2022, 'Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use', in Pain, Wolters Kluwer, United States, Vol. 163, pp. E614 - E621, United States, http://dx.doi.org/10.1097/j.pain.0000000000002433

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson S-A; Dobbins T; Dunlop AJ; Mattick RP; Peacock A, 2021, 'CHARACTERISTICS OF YOUNG PEOPLE AT INDEX ALCOHOL-RELATED HOSPITAL ADMISSIONS AND EMERGENCY DEPARTMENT PRESENTATIONS IN AUSTRALIA: A RETROSPECTIVE DATA LINKAGE COHORT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S154 - S154, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200370&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costa JDO; Pearson S-A; Elshaug A; van Gool K; Jorm L; Falster M, 2021, 'Rates of low value care in NSW public hospitals: variation between public and private inpatients', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, Vol. 50, http://dx.doi.org/10.1093/ije/dyab168.195

Bruno C; Havard A; Hanly M; Falster K; Nassar N; Edwards B; Guastella A; Pearson S-A; Zoega H, 2021, 'Children's relative age and medicine treatment for attention-deficit/hyperactivity disorder (ADHD) across Australian jurisdictions with different school enrolment policies', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 166 - 167, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Daniels B; Pearson S-A; Bruno C; Buckley N; Schaffer A; Jun M; Zoega H, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300446&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Camacho X; Havard A; Zoega H; Wilson M; Gomes T; Vigod S; Pearson S; Henry D, 2020, 'Maternal and Neonatal Outcomes Associated with Psychostimulant Use in Pregnancy', in International Journal of Population Data Science, Swansea University, Vol. 5, http://dx.doi.org/10.23889/ijpds.v5i5.1579

Camacho X; Wilson M; Paterson M; Pearson S; Henry D, 2020, 'Supporting Drug Regulators Through Simple Rapid Cycle Analyses', in International Journal of Population Data Science, Swansea University, Vol. 5, http://dx.doi.org/10.23889/ijpds.v5i5.1581

Falster MO; Buckley NA; Brieger D; Pearson S-A, 2020, 'Antihypertensive polytherapy in Australia: Prevalence of inappropriate combinations, 2013-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 198 - 199

Daniels B; Pearson S-A; Vajdic CM; Pottegard A; Buckley NA; Buckley NA; Zoega H, 2020, 'Risks of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide (HCTZ)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruno C; Costa JDO; Raichand S; Pearson S-A, 2020, 'The Australian pharmacoepidemiology research landscape: The more things change the more they stay the same', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 494 - 495, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640501433&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costa JDO; Bruno C; Baranwal N; Pearson S-A, 2020, 'Variations in long-term opioid use definitions in observational research: A systematic review of studies using routinely collected data', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 174 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500367&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Falster MO; Charrier R; Pearson S; Buckley N; Daniels B, 2020, 'Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Virtual, Vol. 29, pp. 199 - 199, presented at 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, 16 September 2020

Vajdic CM; Perez-Concha O; Rhee J; Dobbins T; Ward R; Schaffer A; Van Leeuwen MT; Laaksonen M; Craigen G; Pearson S, 2019, 'Risk factors for cancer registry-notified cancer of unknown primary site (CUP)', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, Vol. 15, pp. 84 - 85, presented at Clinical Oncology Society of Australia 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13262

Peacock A; Chiu V; Leung J; Dobbins T; Larney S; Gisev N; Pearson S-A; Dunlop AJ; Degenhardt L, 2019, 'CHARACTERISING PEOPLE ATTENDING NEW SOUTH WALES EMERGENCY DEPARTMENTS AND HOSPITALS FOR AN ALCOHOL-RELATED PROBLEM, 2005-2014: THE DATA-LINKAGE ALCOHOL COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S81 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chiu T; Pearson S; Schaffer A, 2019, 'Pregabalin use outside subsidy restrictions in Australia', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, Vol. 28, pp. 252 - 253, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Daniels B; Wylie C; Pearson S-A; Brett J; Buckley N, 2019, 'A day in the life: Prescription medicine use in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 545 - 545, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruno C; Pearson S-A; Daniels B; Buckley N; Zoega H, 2019, 'Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 519 - 519, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785604010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer AL; Buckley NA; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 34 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Falster M; Schaffer A; Jorm L; Wilson A; Brieger D; Nasis A; Emerson L; Pearson S, 2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, Vol. 3, presented at International Population Data Linkage Conference 2018, Banff, Canada, http://dx.doi.org/10.23889/ijpds.v3i4.640

Gisev N; Pearson S; Larance B; Larney S; Blanch B; Degenhardt L, 2018, 'The safety of fentanyl patch initiation in Australian clinical practice: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 437 - 437, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893804049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Homaira N; Daniels B; Pearson S; Jaffe A, 2018, 'PATTERNS OF PRESCRIBED ASTHMA MEDICINE USE IN AUSTRALIAN CHILDREN: A POPULATION-BASED STUDY', in RESPIROLOGY, WILEY, Vol. 23, pp. 107 - 107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427591800192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brieger D; Falster M; Schaffer A; Jorm L; Pearson S; Emerson L; Hay M; Nasis A; Wilson A, 2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, Vol. 27, pp. s333, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia, http://dx.doi.org/10.1016/j.hlc.2018.06.647

Nasis A; Schaffer A; Falster M; Pearson S; Jorm L; Emerson L; Hay M; Brieger D; Wilson A, 2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Vol. 27, pp. s356, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, http://dx.doi.org/10.1016/j.hlc.2018.06.701

Schaffer AL; Buckley NA; Pearson S, 2017, 'Two-Year Statin Adherence Trajectories in Initiators of Combined Amlodipine-Atorvastatin Therapy: A Population-Based Study (2005–2015)', in Abstracts of the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, WILEY, Montreal, Canada, Vol. 26, pp. 519 - 520, presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275

Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Pearse J; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 1: Summary report, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-summary-report.pdf

James P; Mazevska D; McElduff P; Stone C; Tuccia J; Cho O; Mitchell S; McElduff B; Tran D; Falster M; Pearson S; Jorm L; Yu S; Naghsh Nejadm M; van Gool K; Wright M; Hall J; Bower M; Dunbar J; Henryks J; Rosen R; Smyth T, 2022, Health Care Homes trial final evaluation report, Volume 3: Methods and data supplement, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-methods-and-data-supplement.pdf

Tran D; Falster M; Pearson S; Jorm L, 2021, Health Care Homes PHN Benchmark Report: July 2020 - December 2020 (Round 5)

Tran D; Falster M; Pearson S; Jorm L, 2021, Health Care Homes Practice Benchmark Report: July 2020 - December 2020 (Round 5)

Pearse J; Mazevska D; McElduff P; Tuccia J; Stone C; Cho O; Robertson E; Taylor P; Jorm L; Pearson S; Falster M; Tran D; Hall J; van Gool K; Yu S; Dunbar J; McDermott R; Smyth T; Henryks J; Bower M; Rosen R; Sutch S; McDonald K; Lethborg A; Dove C, 2021, Evaluation of the Health Care Homes program - Interim evaluation report 2020 Volume 1: Summary report, https://www1.health.gov.au/internet/main/publishing.nsf/Content/Evaluation-of-the-Health-Care-Homes-Program

Back to profile page